Biognosys is the leading company in next generation proteomics. We offer services and products for precise, high-content protein quantification. Biognosys was founded in 2008 as a spin-off from the ETH Zurich in Switzerland. Located within the Bio-Technopark in Schlieren just outside of Zurich, we operate our own state of the art proteomics facility, providing services to pharma, biotechnology, agriculture and life science companies worldwide.
Our technology quantifies proteins with unbeatable precision and depth. Biognosys' mission is to make next generation proteomics widely available through our contract research services and our portfolio of innovative reagents and software products.
Biognosys’ service offering includes discovery proteomics (DIA-based), targeted proteomics and drug target deconvolution (based on the proprietary LiP-MS technology). These technologies are applied in contract research projects for pharma and biotechnology companies and you will be involved starting from project design all the way through final report presentation to our customers. Together with a strong team of dedicated scientists, you make Biognosys’ next generation proteomics technology available and actionable for the pharma and biotechnology industry.
We offer a dynamic work atmosphere in a young and motivated team. You will profit from an open and flexible company structure where personal initiative is appreciated and encouraged. Biognosys is a fast-growing and internationally acting company that offers you the opportunity to grow together with us in a rapidly emerging and innovative market.